C

Cel-Sci Corp

D
CVM
USD
-0.0911
(-11.3875%)
Market Closed
4,650.00
Volume
-0.51
EPS
-
Div Yield
-1.222241
P/E
43,592,550.04
Market Cap
Today
-6.7114%
1 Week
-20.115%
1 Month
-34.361%
6 Months
-57.804%
12 Months
-67.777%
Year To Date
-73.938%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
M
MYOV
(%)
USD
A
ABEO
0.09
(1.4308%)
USD
C
CTIC
0.11
(2.5404%)
USD
B
BLCM
-0.0162
(-4.0878%)
USD
V
VTVT
-0.45
(-3.2609%)
USD
PFE
PFE
0.105
(0.3839%)
USD
I
IMV
0.01
(1.9608%)
USD
MRNA
MRNA
-1.49
(-2.8776%)
USD
A
ARCT
0.45
(2.4563%)
USD

Title:
Cel/Sci Corp

Sector:
Healthcare
Industry:
Biotechnology
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Do you need help or have a question?
Contact Us